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Abstract
Background: Although data suggest that intakes of total protein and specific amino acids (AAs) reduce blood pressure,
data on other cardiovascular disease risk factors are limited.
Objective:We examined associations between intakes of AAs with knownmechanistic links to cardiovascular health and
direct measures of arterial stiffness, central blood pressure, and atherosclerosis.
Methods: In a cross-sectional study of 1898 female twins aged 18–75 y from the TwinsUK registry, intakes of 7
cardioprotective AAs (arginine, cysteine, glutamic acid, glycine, histidine, leucine, and tyrosine) were calculated from food-
frequency questionnaires. Direct measures of arterial stiffness and atherosclerosis included central systolic blood
pressure (cSBP), mean arterial pressure (MAP), augmentation index (AI), pulse wave velocity (PWV), and intima–media
thickness (IMT). ANCOVA was used to assess the associations between endpoints of arterial stiffness and intake (per
quintile), adjusting for potential confounders.
Results: In multivariable analyses, higher intakes of total protein and 7 potentially cardioprotective AAs were associated
with lower cSBP, MAP, and PWV. Higher intakes of glutamic acid, leucine, and tyrosine were most strongly associated
with PWV,with respective differences of20.46 0.2m/s (P-trend = 0.02),20.46 0.2m/s (P-trend = 0.03), and20.46 0.2m/s
(P-trend = 0.03), comparing extreme quintiles. There was a significant interaction between AA intakes and protein source,
and higher intakes of AAs from vegetable sources were associated with lower central blood pressure and AI. Higher
intakes of glutamic acid, leucine, and tyrosine from animal sources were associated with lower PWV.
Conclusions: These data provide evidence to suggest that intakes of several AAs are associated with cardiovascular
benefits beyond blood pressure reduction in healthy women. The magnitude of the observed associations was similar to
those previously reported for other lifestyle factors. Increasing intakes of these AAs could be an important and readily
achievable way to reduce cardiovascular disease risk. J Nutr 2015;145:2130–8.
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Introduction
Dietary protein intake has received increased attention for its role
in preventing cardiovascular disease, especially in relation to
blood pressure–lowering effects. A higher total protein intake has
been inversely associated with both systolic and diastolic blood
pressure in a number of observational studies (1). Furthermore, a
meta-analysis of 40 randomized, controlled trials reported
significant decreases in blood pressure with increased intakes of
total (systolic 21.8 mm Hg and diastolic 21.2 mm Hg), animal
(systolic22.5 mmHg and diastolic21.0 mmHg), and vegetable
(systolic 22.3 mm Hg and diastolic 21.3 mm Hg) protein (2).
Other studies, however, have found that it is protein from
vegetable sources that is inversely related to blood pressure, with
no significant effects for animal protein (3, 4). Furthermore, plant
protein has been shown to be a strong marker of dietary quality,
whereas the findings for animal protein are currently equivocal
(5).
The mechanisms explaining the vasoactive properties of
dietary protein are likely to be dependent on the amino acid
composition and the source of the protein. A number of amino
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acids, including glutamic acid, arginine, glycine, cysteine, and
histidine, have been shown to modulate concentrations of nitric
oxide, a potent vasodilator (6–9). In addition, leucine has been
shown to modulate insulin/phosphoinositide 3-kinase signaling
in animal models (10), and cysteine has been shown to increase
glucose uptake and concentrations of glucose transporter 3 and
glucose transporter 4 in vitro; in rat models, dietary cysteine has
been shown to reduce insulin resistance and glucose intolerance
(11, 12). Tyrosine is thought to reduce blood pressure by
stimulating catecholamine synthesis in the brain (13), whereas
histidine has been shown to inhibit vascular expression of the
angiotensin converting enzyme mRNA in hypertensive rats (9).
To our knowledge, only one previous cross-sectional study
has examined associations between intakes of amino acids with
established vasoprotective properties and blood pressure and
showed that a higher intake of tyrosine was related to a 2.4 mm
Hg lower systolic blood pressure (14). Other cross-sectional and
longitudinal studies, which have examined associations between
blood pressure and all amino acids, reported inverse associations
between higher intakes of glutamic acid, histidine, and tyrosine
and systolic blood pressure (15–17). Higher intakes of glutamic
acid and cysteine has also been associated with a decreased risk
of stroke mortality and incidence in women (18, 19).
There is evidence to suggest that measures of central arterial
function are better predictors of cardiovascular events than
brachial blood pressure (20). Arterial stiffness provides assess-
ment of both the structure and function of the artery, and pulse
wave velocity (PWV)5 is considered to be the gold standard
measurement and most consistently predictive of cardiovascular
disease risk (20). The measurement of central blood pressure with
the use of the augmentation index (AI) is considered to be a strong
predictor of atherosclerosis (20), and intima–media thickness
(IMT) predicts future incidence of coronary heart disease (21).
To our knowledge, no previous cross-sectional studies have
examined associations between the intakes of these 7 potentially
cardioprotective amino acids and in vivo measures of arterial
stiffness and atherosclerosis. Therefore, we examined associa-
tions between these 7 amino acids, which have known mech-
anistic links to blood pressure, and endpoints of arterial stiffness
(PWVand AI), atherosclerosis (IMT), and central and peripheral
blood pressure in a cohort of healthy women aged 18–75y. On
the basis of previous research, it was hypothesized that partic-
ipants with higher intakes of arginine, cysteine, glutamic acid,
glycine, histidine, leucine, and tyrosine would have improved
arterial stiffness and central blood pressure.
Methods
Study population. The current study used data collected from female
twin pairs in the TwinsUK registry, a nationwide registry that consists of
adult twin volunteers recruited from the general population through
national media campaigns in the United Kingdom (22). All participants
were unaware of the specific hypotheses being tested, and were not
selected on the basis of the variables being studied. Zygosity was derived
by questionnaire and confirmed by multiplex DNA fingerprinting (PE
Applied Biosystems). Informed consent was obtained from all partici-
pants and ethical approval for the study was gained from St. Thomass
Hospital Research Ethics committee. The participants included in this
analysis were female twin pairs aged 18–75 y, and were a sample of the
total population group (n = 5725) who had completed both FFQs and
had a clinical assessment of arterial stiffness and atherosclerosis
progression between 1996 and 2000. Of the 5119 twins who completed
an FFQ, 36% (n = 1857) were excluded for having an incomplete FFQ
(>10 food items were left blank) or implausible energy intake [the ratio
of the FFQ-derived estimate of total energy intake to estimated basal
metabolic rate fell 2 SDs outside the mean ratio (<0.52 or >2.58) for
this cohort] (23). A further 27% of participants (n = 1364) did not
attend a clinical session for vascular assessment, which left 1898
participants (949 twin pairs) for the current analysis. PWV and IMT
were measured in a subset of 900 participants of the total population
who were part of a planned longitudinal study on the heritability of
arterial stiffness, of which 728 (81%) completed a valid FFQ and were
included in these analyses. A power calculation related to a clinically
TABLE 1 Characteristics, vascular function, and dietary intake
of the study population1
Value
Characteristics
Age, y 46.3 6 12.4 (37.0, 56.0)
BMI, kg/m2 25.3 6 4.5 (22.2, 27.4)
Female 100
Dizygotic 70.9
Current smoker 18.6
Physically active 22.7
Uses hormone replacement therapy 16.3
Uses blood pressure or statin medication 10.8
Uses vitamin supplements 54.7
Uses oral contraceptives 2.2
Postmenopausal 40.8
Has family history of hypertension or heart disease 38.2
Vascular function
Peripheral systolic pressure, mm Hg 119 6 16 (108, 129)
Peripheral diastolic pressure, mm Hg 76.2 6 11.3 (68.0, 83.0)
Central systolic pressure, mm Hg 111 6 17 (99, 121)
Central diastolic pressure, mm Hg 77.4 6 11.5 (70.0, 84.8)
Central pulse pressure, mm Hg 33.5 6 9.3 (27.0, 38.0)
Mean arterial pressure, mm Hg 92.3 6 13.3 (76.4, 96.3)
Augmentation index, % 138 6 26 (122, 156)
Pulse wave velocity,2 m/s 9.1 6 1.8 (8.0, 10.1)
Intima–media thickness,2 mm 0.7 6 0.2 (0.6, 0.8)
Dietary intake
Energy, kcal/d 2007 6 534 (1632, 2348)
Protein, g/d 80.2 6 21.6 (65.3, 93.9)
Protein as a proportion of body weight, g/kg 1.2 6 0.4 (1.0, 1.5)
Arginine, % protein/d 5.4 6 0.4 (5.2, 5.7)
Cysteine, % protein/d 1.4 6 0.1 (1.4, 1.5)
Glutamic acid, % protein/d 19.8 6 1.1 (19.1, 20.4)
Glycine, % protein/d 4.0 6 0.3 (3.8, 4.2)
Histidine, % protein/d 2.8 6 0.1 (2.7, 2.9)
Leucine, % protein/d 7.9 6 0.2 (7.8, 8.0)
Tyrosine, % protein/d 3.5 6 0.1 (3.4, 3.5)
Carbohydrates, % energy/d 48.2 6 6.3 (44.4, 52.2)
Saturated fat, % energy/d 11.6 6 2.9 (9.65, 13.4)
Monounsaturated fat, % energy/d 10.4 6 2.2 (9.0, 11.8)
Polyunsaturated fat, % energy/d 6.9 6 1.7 (5.8, 8.0)
Alcohol, g/d 9.9 6 13.6 (1.2, 13.4)
Sodium, mg/d 2300 6 785 (1760, 2750)
Potassium, mg/d 4200 6 1110 (3430, 4850)
Magnesium, mg/d 364 6 100 (295, 422)
1 Values are means 6 SDs (IQRs) or percentages, n = 1898.
2 Subset analysis for 728 participants.
5 Abbreviations used: AI, augmentation index; cPP, central pulse pressure;
cSBP, central systolic blood pressure; IMT, intima–media thickness; INTERMAP,
INTERnational study of MAcro- and micronutrients and blood Pressure; MAP,
mean arterial pressure; pDBP, peripheral diastolic blood pressure; pSBP,
peripheral systolic blood pressure; PWV, pulse wave velocity.
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significant associationwith a PWVof 0.4 m/s at an a level of 0.05 revealed
98% power to see an association with 728 participants. This population
has previously been shown to be representative of the general population
in terms of blood pressure and dietary intake (22, 23).
Assessment of arterial stiffness, central blood pressure and IMT.
Measurements were performed during a single visit to a quiet,
temperature-controlled (22–24C) clinical laboratory. Peripheral systolic
blood pressure (pSBP) and peripheral diastolic blood pressure (pDBP)
were measured by a trained nurse who used an automated cuff
sphygmomanometer (OMRON HEM713C) with the participant in
the seated position for at least 3 min before taking 3 measurements.
Measures of central blood pressure and AI were obtained with the subject
in a supine position with the use of the SphygmoCor system (Atcor
Medical), as described previously for this cohort (24). Intraoperator
and interoperator reproducibility, expressed as intraclass correlations,
were 0.82 and 0.84, respectively (25). In a subset of the population (n =
728) who were part of a study on the heritability of arterial stiffness,
PWV was calculated from sequential recordings of electrocardiogram-
referenced carotid and femoral pressure waveforms obtained by
tonometry with the use of the same device and transducer, as previous
described (26).
Assessment of amino acid intake. Participants completed a 131-item
validated FFQ (27, 28). Intakes of amino acids were derived predom-
inantly with the use of UK food composition data but with additional
data from the USDA (29, 30). The intake of glutamic acid in these
datasets relates to glutamic acid plus glutamine. Values for 18 individual
amino acids were assigned to each of the foods listed in the FFQ, and for
recipes, values for each ingredient in the dishes were assigned with the
use of the data sources described above. When values for total protein
from the amino acid database and the latest UK food composition tables
differed, the amino acid composition of the food items was modified to
match the most up-to-date data (29). Intake of individual amino acids
was calculated as the frequency of consumption of each food multiplied
by the amino acid content of the food for the appropriate portion size
(31). All foods were classified as of either animal or vegetable origin and
for mixed dishes the proportions contributed by animal and vegetable
sources were calculated by breaking down the ingredients into foods that
were attributable to a single source. Amino acid data are presented as a
percentage of total energy intake in order to best represent the relative
proportion to total dietary intake.
Assessment of covariates. Intakes of energy and nutrients associated
with arterial stiffness was determined from the FFQ as previously
described. Height was measured to the nearest 0.5 cm with the use of a
wall-mounted stadiometer, weight (light clothing only) was measured to
the nearest 0.1 kg with digital scales, and BMI was calculated (kilograms
per meter squared). Information on family medical history, medication
use, lifestyle, and demographic variables were obtained by standardized
nurse-administered questionnaire. Physical activity was classified as
inactive, moderate, and active during work, home, and leisure time with
the use of a questionnaire strongly correlated in this cohort with
more in-depth assessment recording how much time subjects spent in
moderate and vigorous nonweight-bearing and weight-bearing activity
on average per week. The mean time spent in physical activity per week
for each physical activity level was as follows: inactive, 16 min; light
activity, 36 min; moderate activity, 102 min; and heavy activity, 199 min
(32). Under-reporting of energy intake was based on a comparison of
total predicted energy expenditure with reported energy intake and
establishing quantitative limits to define under-reporters based on CIs
calculated by taking into account within-subject variation in energy
intake and expenditure (33, 34). Because excluding participants who
under-report can introduce considerable bias, under-reporting was
considered to be a covariate in all multivariable models (35).
Statistical analysis. Statistical analyses were performed with Stata
statistical software, version 11.2. The analysis focused on associations in
twins as individuals, with SEs adjusted through robust regression with
the use of the cluster option in Stata to take into account dependency
within twin pairs. Quintiles of intake were calculated for total protein
and the amino acids with known mechanistic links to outcomes
associated with cardiovascular disease (arginine, cysteine, glutamic
acid, glycine, histidine, leucine, and tyrosine). There was a significant
interaction between amino acid intake and protein source for PWV, so all
analyses were stratified by source (all, vegetable, and animal). ANCOVA
was used to calculate adjusted means and evaluate statistical trends
across these quintiles of intake. All models were adjusted for age (years);
current smoking (yes or no); physical activity (inactive, moderately
active, or active); BMI (kilograms per meter squared); use of hormone
replacement therapy (yes or no); use of blood pressure or statin
medication (yes or no); use of vitamin supplements (yes or no); use of
oral contraceptives (yes or no); menopausal status (pre- or postmeno-
pausal); family history of heart disease or hypertension (yes or no);
under-reporting of dietary intake (yes or no); and intake of carbohy-
drates (percentage of energy); SFAs, MUFAs, and PUFAs (percentage of
energy); alcohol (grams); and sodium, potassium, and magnesium
(milligrams). In addition, models including individual amino acids
were adjusted for intakes of the other 6 amino acids and PWV was
adjusted for mean arterial pressure (MAP). Unadjusted values in the text
are means6 SDs (IQRs) and adjusted values are means6 SEs. A P value
< 0.05 was considered to be statistically significant.
Results
The baseline characteristics of the population of 1898 female
participants are presented in Table 1. A total of 83.3% (n = 1581)
of participants classified as normotensive (pSBP <140mmHg and
pDBP <90 mmHg; data not shown). There were no differences in
BMI, energy intake, or protein intake between the study partic-
ipants and those excluded from the analyses; however, the
participants were younger than those excluded (46.46 12.4 y vs.
50.6 6 12.9 y, P < 0.01; data not shown).
Total protein intake was 85.1 6 23.4 g/d and protein
contributed 16.2% to total energy intake. Of the 7 amino acids
investigated, glutamic acid (3.2% energy intake) and leucine (1.3%
energy intake) made the greatest contribution to total energy
intake. Animal and vegetable sources contributed a similar amount
to intakes of arginine (52% animal), glutamic acid (51% animal),
and glycine (55% animal), whereas intakes of histidine (60%
animal), tyrosine (62% animal), and leucine (61% animal) was
predominantly from animal sources (Figure 1). Conversely, vege-
table sources contributed more to cysteine intake (42% animal).
Generally, correlations between the amino acids investigated ranged
from 0.03 (glutamic acid and leucine) to 0.61 (leucine and tyrosine),
although stronger correlations were observed between glycine and
leucine (0.70) and arginine and glycine (0.77).
FIGURE 1 The percentage contribution of animal and vegetable
foods to amino acid intake and key dietary sources in 1898 women
aged 18–75 y.
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In multivariable analyses, higher intakes of total protein and
the 7 individual amino acids examined were significantly associ-
ated with lower peripheral and central blood pressure (Table 2),
with the exception of total protein for central pulse pressure (cPP)
(P-trend 0.06) and glycine for pDBP (P-trend 0.11) and cen-
tral diastolic blood pressure (P-trend = 0.08). The magnitude of
association was greatest for tyrosine intake, with differences
between quintile 5 and quintile 1 of25.66 1.3 mm Hg for pSBP
(P-trend < 0.01), 25.5 6 1.3 mm Hg for central systolic blood
pressure (cSBP) (P-trend < 0.01), 22.3 6 0.7 mm Hg for cPP
(P-trend < 0.01), and 24.0 6 1.1 mm Hg for MAP (P-trend <
0.01) (Table 2). A higher leucine intake was also associated with
significantly lower systolic blood pressure (peripheral and central),
cPP, and MAP, with differences between extreme quintiles of
intake of25.46 1.3mmHg (P-trend < 0.01),25.56 1.3mmHg
(P-trend < 0.01),22.66 0.7mmHg (P-trend < 0.01), and23.86
1.1 mm Hg (P-trend < 0.01), respectively. For arterial stiffness,
glutamic acid, leucine, and tyrosine intakes were significantly
inversely associated with PWV (after adjustment for MAP) with
respective differences of20.46 0.2 m/s (P-trend = 0.01),20.46
0.2 m/s (P-trend = 0.04) and 20.4 6 0.2 m/s (P-trend = 0.02),
comparing extremes of intake. Sensitivity analysis showed that the
magnitude of associations with PWV were not markedly changed
when protein was residually adjusted for energy intake (Q5–Q1,
–0.26 0.2 m/s, P-trend = 0.10), when amino acids were expressed
as a percentage of protein (leucine Q5–Q1, –0.5 6 0.2 m/s,
P-trend 0.03; tyrosine Q5–Q1, –0.4 6 0.2 m/s, P-trend = 0.04;
glutamic acid Q5–Q1, –0.4 6 0.2 m/s, P-trend = 0.19), or when
potential under-reporters of energy intake were excluded from
the analyses (leucine Q5–Q1, –0.6 6 0.3 m/s, P-trend = 0.05;
tyrosine Q5–Q1, –0.5 6 0.3 m/s, P-trend = 0.06; glutamic acid
Q5–Q1, –0.2 6 0.3 m/s, P-trend = 0.08).
No significant associations were observed between intake of
total protein or the individual amino acids assessed and either AI or
IMT (data not shown). The results were not altered after exclusion
of the low proportion (11%) of participants who reported taking
blood pressure or statin medication (data not shown).
Higher intakes of amino acids from vegetable sources were
inversely associated with cSBP and AI. Intakes of arginine,
glycine, histidine, leucine and tyrosine were significantly asso-
ciated with 22.0 to 22.4 mm Hg lower cSBP values and intake
of cysteine, glutamic acid, lysine, and tyrosine with 23.5% to
25.7% lower AI, comparing extreme quintiles of intake (all
P-trend < 0.05) (Table 3). Higher intakes of arginine and glycine
from vegetable sources were also significantly associated with
lower pSBP (arginine Q5–Q1, 22.3 6 1.4 mm Hg, P-trend =
0.02; and glycine Q5–Q1, 22.6 6 1.5 mm Hg, P-trend = 0.04)
(Table 3). Furthermore, intake of arginine from vegetable
sources was associated with lower cPP (Q5–Q1, 21.2 6 0.8 mm
Hg, P-trend = 0.04) and MAP (Q5–Q1, 21.2 6 1.1 mm Hg,
P-trend = 0.03). In relation to intakes of amino acids from
animal sources, significant inverse associations were observed
between glutamic acid, leucine, and tyrosine intakes and PWV,
with respective differences of 20.3 6 0.2 m/s (P-trend = 0.03),
20.36 0.2 m/s (P-trend = 0.02), and20.46 0.2 m/s (P-trend =
0.02) between extreme quintiles of intake. Total vegetable
protein intake and total animal protein intake were not associated
with any of the outcomes assessed (P-trend all > 0.05), and there
were no significant associations for IMT (data not shown).
Discussion
To our knowledge, this is the first cross-sectional study to examine
associations between amino acids that have known mechanisticT
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TABLE 3 Measures of central blood pressure and arterial stiffness between extreme quintiles of total
protein and individual amino acids from vegetable and animal sources in women aged 18–75 y1
Protein Arginine Cysteine Glutamic acid Glycine Histidine Lysine Tyrosine
Vegetable sources
Intake, % energy
Q1 4.6 6 0.4 0.3 6 0.03 0.1 6 0.01 1.0 6 0.1 0.2 6 0.02 0.1 6 0.01 0.3 6 0.04 0.1 6 0.02
Q2 5.4 6 0.2 0.3 6 0.01 0.1 6 0.00 1.2 6 0.05 0.2 6 0.01 0.1 6 0.00 0.4 6 0.03 0.2 6 0.01
Q3 6.0 6 0.2 0.3 6 0.01 0.1 6 0.00 1.3 6 0.04 0.3 6 0.01 0.2 6 0.00 0.4 6 0.03 0.2 6 0.02
Q4 6.6 6 0.2 0.4 6 0.01 0.1 6 0.00 1.5 6 0.06 0.3 6 0.01 0.2 6 0.01 0.5 6 0.03 0.2 6 0.02
Q5 8.0 6 0.9 0.5 6 0.1 0.2 6 0.02 1.8 6 0.2 0.3 6 0.04 0.2 6 0.03 0.6 6 0.1 0.2 6 0.04
pSBP, mm Hg
Q5–Q1 22.6 6 1.5 22.3 6 1.4 0.3 6 1.7 20.2 6 1.7 22.6 6 1.5 22.1 6 1.4 22.0 6 1.4 22.0 6 1.4
P-trend 0.12 0.02 0.96 0.78 0.04 0.05 0.05 0.05
pDBP, mm Hg
Q5–Q1 21.9 6 1.0 20.9 6 0.9 21.0 6 1.1 21.0 6 1.1 21.1 6 1.0 21.6 6 1.0 21.6 6 0.9 21.6 6 0.9
P-trend 0.07 0.08 0.29 0.27 0.15 0.05 0.03 0.04
cSBP, mm Hg
Q5–Q1 22.8 6 1.5 22.1 6 1.3 20.2 6 1.6 20.7 6 1.6 22.4 6 1.4 22.1 6 1.4 22.0 6 1.3 22.0 6 1.3
P-trend 0.08 0.02 0.71 0.63 0.03 0.04 0.03 0.04
cDBP, mm Hg
Q5–Q1 21.7 6 1.0 21.0 6 1.0 20.8 6 1.1 20.7 6 1.1 21.0 6 1.0 21.5 6 1.0 21.3 6 1.0 21.3 6 1.0
P-trend 0.11 0.09 0.39 0.41 0.17 0.07 0.07 0.07
cPP, mm Hg
Q5–Q1 21.2 6 0.9 21.2 6 0.8 0.5 6 0.9 20.1 6 0.9 21.4 6 0.8 20.6 6 0.8 20.7 6 0.7 20.7 6 0.7
P-trend 0.29 0.04 0.66 0.88 0.04 0.23 0.15 0.15
MAP, %
Q5–Q1 21.8 6 1.2 21.2 6 1.1 20.6 6 1.3 20.2 6 1.3 21.7 6 1.2 21.8 6 1.1 21.5 6 1.1 21.5 6 1.1
P-trend 0.13 0.03 0.51 0.71 0.05 0.05 0.06 0.06
AI, mm Hg
Q5–Q1 23.8 6 2.3 21.6 6 2.2 24.3 6 2.3 25.7 6 2.4 21.7 6 2.2 21.6 6 2.3 23.5 6 2.1 23.6 6 2.1
P-trend 0.07 0.18 0.03 0.03 0.06 0.19 0.03 0.03
PWV,2 mm Hg
Q5–Q1 20.2 6 0.2 0.1 6 0.2 20.2 6 0.2 20.3 6 0.2 20.0 6 0.3 20.1 6 0.2 20.2 6 0.2 20.2 6 0.2
P-trend 0.32 0.74 0.15 0.21 0.99 0.65 0.26 0.46
Animal sources
Intake, % energy
Q1 6.3 6 1.2 0.3 6 0.1 0.1 6 0.01 1.2 6 0.2 0.2 6 0.05 0.2 6 0.04 0.5 6 0.1 0.2 6 0.04
Q2 8.6 6 0.4 0.4 6 0.02 0.1 6 0.05 1.6 6 0.1 0.3 6 0.02 0.3 6 0.01 0.7 6 0.04 0.3 6 0.02
Q3 9.9 6 0.4 0.5 6 0.02 0.1 6 0.02 1.8 6 0.1 0.4 6 0.02 0.3 6 0.01 0.8 6 0.04 0.4 6 0.02
Q4 11.4 6 0.5 0.6 6 0.03 0.1 6 0.01 2.1 6 0.1 0.4 6 0.02 0.3 6 0.02 0.9 6 0.05 0.4 6 0.02
Q5 14.1 6 1.6 0.8 6 0.1 0.2 6 0.02 2.5 6 0.3 0.6 6 0.1 0.4 6 0.05 1.2 6 0.1 0.5 6 0.1
pSBP, mm Hg
Q5–Q1 21.9 6 1.4 22.2 6 1.3 21.3 6 1.3 22.2 6 1.3 21.8 6 1.3 22.1 6 1.4 22.1 6 1.3 22.1 6 1.3
P-trend 0.17 0.07 0.30 0.21 0.12 0.17 0.11 0.1
pDBP, mm Hg
Q5–Q1 21.6 6 1.0 21.7 6 0.9 21.4 6 1.0 22.0 6 1.0 21.4 6 1.0 21.4 6 1.0 21.9 6 1.0 21.9 6 1.0
P-trend 0.11 0.10 0.19 0.07 0.14 0.12 0.05 0.05
cSBP, mm Hg
Q5–Q1 22.1 6 1.3 22.2 6 1.3 21.5 6 1.3 22.5 6 1.3 21.7 6 1.3 22.2 6 1.4 22.3 6 1.3 22.4 6 1.3
P-trend 0.15 0.10 0.30 0.17 0.16 0.16 0.10 0.08
cDBP, mm Hg
Q5–Q1 21.5 6 1.0 21.7 6 0.9 21.5 6 1.0 21.9 6 1.0 21.4 6 1.0 21.3 6 1.0 21.7 6 1.0 21.8 6 1.0
P-trend 0.18 0.13 0.22 0.11 0.15 0.18 0.09 0.08
cPP, mm Hg
Q5–Q1 20.6 6 0.7 20.5 6 0.7 20.0 6 0.7 20.6 6 0.7 20.3 6 0.7 20.9 6 0.7 20.6 6 0.7 20.6 6 0.7
P-trend 0.43 0.35 0.84 0.73 0.54 0.44 0.50 0.47
MAP, %
Q5–Q1 21.4 6 1.1 21.7 6 1.1 21.3 6 1.1 21.7 6 1.1 21.5 6 1.1 21.5 6 1.1 21.6 6 1.1 21.7 6 1.1
P-trend 0.29 0.16 0.36 0.25 0.19 0.23 0.17 0.14
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links to cardiovascular disease and a range of in vivo measures of
arterial stiffness and central blood pressure associated with
cardiovascular disease risk.We showed that higher intakes of all 7
of the amino acids examined (arginine, cysteine, glutamic acid,
glycine, histidine, leucine, and tyrosine) were significantly asso-
ciated with improved measures of peripheral and central blood
pressure. Higher intakes of glutamic acid, leucine, and tyrosine
were also associated with lower PWV. These associations were
significant after adjustment for a number of important covariates
known to be associated with vascular health, including lifestyle
factors, medication use, and other nutrients. Themagnitude of the
inverse associations ranged from 22.8 to 25.5 mm Hg for
systolic blood pressure,21.5 to23.2 mmHg for central diastolic
blood pressure, and 20.40 to 20.45 m/s for PWV.
It was previously estimated that a modest reduction in
systolic blood pressure of 5 mm Hg would potentially lead to an
overall reduction in mortality from stroke, coronary heart
disease, or all-cause mortality (36). Intakes of the amino acids
investigated in the current study were associated with a mean
difference in pSBP of 24.1 mm Hg (range: 22.6 to 25.6 mm
Hg). The magnitude of these associations is similar to those
previously reported for established lifestyle risk factors for
hypertension, including sodium intake, physical activity, and
alcohol consumption (37). For PWV, the scale of the association
was 0.4 m/s, which is similar to the magnitude of change
previously associated with not smoking supplementation with
n–3 FAs and, to the differences observed between individuals
with or without metabolic syndrome, hypertension, or hyper-
cholesterolemia (38, 39).
Our results provide further insights into the vascular effects
of these amino acids and a potential explanation to support the
reduction in blood pressure observed with higher protein intake
in a recent meta-analysis (2). Our findings are consistent with
randomized, controlled trials reporting decreases in pSBP of
2 mmHg with 40 g of milk or soy protein and 1.4 mmHg with a
diet substituting 10% of energy from carbohydrate with that
from protein (40, 41). Furthermore, cross-sectional studies of
amino acid intake and blood pressure have reported intakes of
tyrosine and glutamic acid to be associated with, on average, a
2 mmHg reduction in pSBP (14, 15), and intake of histidine with
a 4% reduced risk of an increase in pSBP of 16 mm Hg (16).
These current results, however, do not support the findings of
the INTERMAP (INTERnational study of MAcro- and micro-
nutrients and blood Pressure), which showed that higher glycine
intake was associated with an increase in blood pressure,
and those of the Rotterdam study, which found no signif-
icant associations between intakes of glutamic acid, arginine, and
cysteine and blood pressure or risk of hypertension (14, 17). A
number of factors, including study design, could account for
these divergent findings; interestingly, there were differences
in habitual dietary patterns between studies and consequently
in the major sources of amino acids. For example, in the
INTERMAP, meat contributed to 33–47% of dietary glycine
intake and fish to 6–13%, compared with 25% and 18%,
respectively, in our participants. Food sources of protein vary
greatly in their nonprotein constituents and have previously
been shown to have differing associations with cardiovascular
disease risk in women, with red meat associated with a 13%
increased risk and fish intake with a 19% reduced risk (42).
Because of the strong interrelations previously reported
between blood pressure and protein source, and because we
observed a significant interaction in the current analyses, we
further examined the relation between amino acid intake and
arterial stiffness according to protein source. Protein from
vegetable sources, but not animal sources, has previously been
shown to be associated with a 21.1 mm Hg reduction in pSBP
and 15% reduction in risk of hypertension (3, 4). We found
that higher intakes of amino acids from vegetable sources, but
not animal sources, were associated with lower systolic blood
pressure, MAP, and AI. Intakes of glutamic acid, leucine, and
tyrosine from animal sources were associated with lower a PWV
of 0.3–0.4 m/s between extreme quintiles of intake. These data
provide support for a previous study from Japan reporting an
inverse relation between higher animal protein intake and blood
pressure (43), but do not support those studies in Western
populations in which animal protein was found to be unrelated
to blood pressure (3). Fish in the current study contributed >3
times more to glutamic acid intake than previously reported in a
UK cohort, which may offer some explanation for this finding
(15). Studies in hypertensive rats provide evidence to suggest
that protein from fish is more effective at lowering blood
pressure than casein over a 2 mo period (44), and a meta-
analysis of adult human trials revealed that n–3 FAs were
effective at improving PWV by 0.33 m/s (39). Fish intake has
also been associated with overall diet quality (5). The underlying
mechanism of interaction between amino acid intake and PWV
observed in the current study is unclear, and it must be
considered that in our study animal sources contributed more
to leucine and tyrosine than vegetable sources; these analyses
may be reflecting our findings for intake from all sources, which
TABLE 3 Continued
Protein Arginine Cysteine Glutamic acid Glycine Histidine Lysine Tyrosine
AI, mm Hg
Q5–Q1 21.4 6 2.2 20.1 6 2.1 21.3 6 2.1 21.5 6 2.2 20.9 6 2.2 20.9 6 2.2 22.1 6 2.2 22.5 6 2.1
P-trend 0.85 0.71 0.79 0.75 0.85 0.95 0.73 0.58
PWV,2 mm Hg
Q5–Q1 20.1 6 0.2 20.1 6 0.2 20.2 6 0.2 20.3 6 0.2 20.0 6 0.2 20.1 6 0.2 20.3 6 0.2 20.4 6 0.2
P-trend 0.11 0.44 0.25 0.03 0.69 0.22 0.02 0.02
1 Values are means 6 SEs between quintile 5 and quintile 1 (except for Intake, for which values are unadjusted means 6 SDs), n = 1898
(Q1 = 380, Q2 = 380, Q3 = 379, Q4 = 380, Q5 = 379). Means are adjusted for age; current smoking; physical activity; BMI; use of hormone
replacement therapy, blood pressure or statin medication, vitamin supplements, or oral contraceptives; menopausal status; family history of
heart disease or hypertension; under-reporting of dietary intake; and intakes of carbohydrates, SFAs, MUFAs, PUFAs, alcohol, sodium,
potassium, and magnesium. Intakes of total protein and individual amino acids from animal sources and intakes from vegetable sources
were mutually adjusted for one another, and in addition PWV was adjusted for MAP. AI, augmentation index; cDBP, central diastolic blood
pressure; cPP, central pulse pressure; cSBP, central systolic blood pressure; MAP, mean arterial pressure; pDBP, peripheral diastolic blood
pressure; pSBP, peripheral systolic blood pressure; PWV, pulse wave velocity; Q, quintile.
2 Subset analysis for 728 participants. Participant numbers were as follows: Q1 = 140, Q2 = 146, Q3 = 150, Q4 = 147, and Q5 = 145.
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were inherently adjusted for protein source. The reasons why we
observed associations with total protein and not animal protein
when the correlation between total and animal protein intakes
was so high (r = 0.89, P < 0.01) remains unclear.
The findings of the current study reflect intakes of amino acids
that are readily achievable in the habitual diet. The difference in
PWV of 0.4 m/s shown between extreme quintiles of intakes of
glutamic acid, leucine, and tyrosine equates to a 3.53 g, 1.64 g,
and 0.76 g difference in intake, respectively. This intake can be
incorporated into the diet by consuming approximately one-half
of amedium steak (74 g), amedium salmon fillet (100 g), or a 500mL
glass of skimmed milk.
Strengths of the current study include the large sample of
well-characterized participants and the rigorous assessment of a
range of in vivo measures of arterial stiffness and central blood
pressure. It is well established that aortic stiffness, as assessed by
PWV, is able to predict future cardiovascular events and all-
cause mortality (45). The publication of reference values for
PWV and the addition of PWV to traditional risk biomarkers in
recent guidelines for hypertension management demonstrate
prognostic ability (46, 47). It was notable that the associations
observed in the current analysis were shown in a population in
which over 80% were classified as normotensive, and it is
plausible that any associations would be more pronounced in a
hypertensive group. These participants previously have been
shown to be representative of the general population in terms of
blood pressure and diet (23, 24), and these data have been used
in previous studies of dietary exposure (48). The FFQ used in the
current study was used to rank participants according to their
amino acid intake. Although the FFQ has not been shown to
accurately quantify amino acid intake, it has previously been
validated against 24 h recalls and shown to classify over 85% of
participants into the same or adjacent quintile of protein intake,
demonstrating its ability to rank participants according to their
habitual protein intake (49).
The limitations of the current study include the cross-
sectional design that meant we were unable to infer causal-
ity Numerous hypothesis-driven comparisons were made in our
analysis that we felt were justified, given the novel and ex-
ploratory nature of the analyses. The inclusion of twin pairs
within the same sample may introduce bias, but this was reduced
by accounting for the clustering within twin pairs in all statistical
analyses and with the use of a sample shown to be representative
of the general population in terms of outcome variables and
dietary intake. Validated biomarkers, such as 24 h urine nitrogen,
are available for total protein intake, but they were not measured
in the current study and may have reduced potential measure-
ment error (50). Furthermore, residual confounding may have oc-
curred despite the multivariable modeling adjusted for a range of
dietary and lifestyle confounder variables (such as age, smoking,
physical activity, BMI, medication use, and intakes of other
nutrients associated with vascular health).
In conclusion, these novel data suggest that intakes of
selected amino acids is associated with arterial stiffness and
central blood pressure, with significant associations observed for
PWV and cSBP similar in magnitude to established lifestyle risk
factors for hypertension, such as physical activity, not smoking,
and reduced intakes of sodium and alcohol (37, 38). The intakes
of amino acids associated with lower arterial stiffness and
central blood pressure are easily achievable in the habitual diet,
making these findings very relevant for public health strategies to
reduce cardiovascular disease risk. Our findings highlight the
need for more intervention trials examining dietary achievable
intakes of amino acids and cardiovascular outcomes.
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